1. Home
  2. CLSD vs AGMH Comparison

CLSD vs AGMH Comparison

Compare CLSD & AGMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • AGMH
  • Stock Information
  • Founded
  • CLSD 2011
  • AGMH 2015
  • Country
  • CLSD United States
  • AGMH Hong Kong
  • Employees
  • CLSD N/A
  • AGMH N/A
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • AGMH EDP Services
  • Sector
  • CLSD Health Care
  • AGMH Technology
  • Exchange
  • CLSD Nasdaq
  • AGMH Nasdaq
  • Market Cap
  • CLSD 20.4M
  • AGMH 17.1M
  • IPO Year
  • CLSD 2016
  • AGMH 2018
  • Fundamental
  • Price
  • CLSD $3.68
  • AGMH $4.54
  • Analyst Decision
  • CLSD Hold
  • AGMH
  • Analyst Count
  • CLSD 4
  • AGMH 0
  • Target Price
  • CLSD $65.00
  • AGMH N/A
  • AVG Volume (30 Days)
  • CLSD 29.9K
  • AGMH 134.7K
  • Earning Date
  • CLSD 11-07-2025
  • AGMH 11-18-2025
  • Dividend Yield
  • CLSD N/A
  • AGMH N/A
  • EPS Growth
  • CLSD N/A
  • AGMH N/A
  • EPS
  • CLSD N/A
  • AGMH 16.43
  • Revenue
  • CLSD $4,166,000.00
  • AGMH $48,526,743.00
  • Revenue This Year
  • CLSD $98.20
  • AGMH N/A
  • Revenue Next Year
  • CLSD $213.77
  • AGMH N/A
  • P/E Ratio
  • CLSD N/A
  • AGMH $0.21
  • Revenue Growth
  • CLSD N/A
  • AGMH 18.80
  • 52 Week Low
  • CLSD $3.32
  • AGMH $1.09
  • 52 Week High
  • CLSD $17.40
  • AGMH $99.47
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 51.21
  • AGMH 43.98
  • Support Level
  • CLSD $3.68
  • AGMH $4.41
  • Resistance Level
  • CLSD $4.08
  • AGMH $4.70
  • Average True Range (ATR)
  • CLSD 0.26
  • AGMH 0.47
  • MACD
  • CLSD -0.13
  • AGMH -0.22
  • Stochastic Oscillator
  • CLSD 2.86
  • AGMH 23.10

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About AGMH AGM Group Holdings Inc.

AGM Group Holdings Inc is an integrated technology company. The company focuses on blockchain-oriented ASIC chip design, high-end crypto miner production, and fintech technology software services. The company generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.

Share on Social Networks: